Author:
Engel Hansjürg,Gutiérrez-Fernández Javier,Flückiger Christine,Martínez-Ripoll Martín,Mühlemann Kathrin,Hermoso Juan A.,Hilty Markus,Hathaway Lucy J.
Abstract
ABSTRACTFosfomycin targets the first step of peptidoglycan biosynthesis inStreptococcus pneumoniaecatalyzed by UDP-N-acetylglucosamine enolpyruvyltransferase (MurA1). We investigated whether heteroresistance to fosfomycin occurs inS. pneumoniae. We found that of 11 strains tested, all but 1 (Hungary19A) displayed heteroresistance and that deletion ofmurA1abolished heteroresistance. Hungary19Adiffers from the other strains by a single amino acid substitution in MurA1 (Ala364Thr). To test whether this substitution is responsible for the lack of heteroresistance, it was introduced into strain D39. The heteroresistance phenotype of strain D39 was not changed. Furthermore, no relevant structural differences between the MurA1 crystal structures of heteroresistant strain D39 and nonheteroresistant strain Hungary19Awere found. Our results reveal that heteroresistance to fosfomycin is the predominant phenotype ofS. pneumoniaeand that MurA1 is required for heteroresistance to fosfomycin but is not the only factor involved. The findings provide a caveat for any future use of fosfomycin in the treatment of pneumococcal infections.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献